KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Shares Issued (2016 - 2026)

Medtronic's Shares Issued history spans 13 years, with the latest figure at $164.0 million for Q1 2026.

  • For Q1 2026, Shares Issued fell 2.38% year-over-year to $164.0 million; the TTM value through Jan 2026 reached $527.0 million, up 10.25%, while the annual FY2025 figure was $508.0 million, 78.87% up from the prior year.
  • Shares Issued for Q1 2026 was $164.0 million at Medtronic, up from $160.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $168.0 million in Q1 2025 and bottomed at $43.0 million in Q3 2022.
  • The 5-year median for Shares Issued is $89.0 million (2024), against an average of $98.5 million.
  • The largest annual shift saw Shares Issued crashed 64.1% in 2022 before it surged 194.74% in 2025.
  • A 5-year view of Shares Issued shows it stood at $110.0 million in 2022, then crashed by 34.55% to $72.0 million in 2023, then skyrocketed by 98.61% to $143.0 million in 2024, then grew by 11.89% to $160.0 million in 2025, then grew by 2.5% to $164.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Shares Issued are $164.0 million (Q1 2026), $160.0 million (Q4 2025), and $95.0 million (Q3 2025).